✨ Your Portfolio is fetched and updated from zerodha.
Small Diagnostic Chains
Market Cap
₹6,335 Cr.
P/E
46.03

Key Ratios

Market cap
Market cap
6,335 Cr
PE
PE
46.03
Prom Holding
Prom Holding
60.93 %
ROE (%)
ROE (%)
16.60
ROCE (%)
ROCE (%)
26.79
Div Yield (%)
Div Yield (%)
1.76
Sales
Sales
792 Cr
OPM (%)
OPM (%)
30.88 %
Debt to Equity
Debt to Equity
-

About

Thyrocare Technologies Ltd. is India's first fully automated diagnostic laboratory with a focu… Read more
Low
219
52W Range
High
537
  • Thyrocare Tech.
  • Vijaya Diagnostic
  • Metropolis Health.
  • TJI Diagnostic Chains

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Capex

Pathology vs Radiology

Asset Break-Up

Operational Metrics

    Select a Metric
    • Number of Daily Patients - Diagnostic Centres (Ths)
    • Number of Samples - Quarterly (Million)
    • No of Tests - Quarterly (Mn)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Thyrocare Technologies Ltd. Business

    Thyrocare Technologies Ltd. is India's first fully automated diagnostic laboratory, offering quality services at affordable rates to laboratories and hospitals in India and abroad through its Centralized and Regional Processing Laboratories.

    Thyrocare Tech. major competitors are Vijaya Diagnostic, Metropolis Health., Vimta Labs, Krsnaa Diagnostics, Nidan Labs. & Health, Dr. Lal Pathlabs, Jeena Sikho Life.
    Market Cap of Thyrocare Tech. is ₹6,439 Crs.
    While the median market cap of its peers are ₹8,685 Crs.

    Thyrocare Tech. seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material